MedPath

成都生物制品研究所有限责任公司

Ownership
-
Established
1981-11-25
Employees
-
Market Cap
-
Website
http://www.cdibp.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

Haemophilus Influenzae Type b Conjugate Vaccine

Product Name
b型流感嗜血杆菌结合疫苗
Approval Number
国药准字S20130006
Approval Date
Mar 1, 2023
NMPA

23-Valent Pneumococcal Polysaccharide Vaccine

Product Name
惠益康
Approval Number
国药准字S20060029
Approval Date
Oct 11, 2021
NMPA

Vi Polysaccharide Typhoid Vaccine

Product Name
伤寒Vi多糖疫苗
Approval Number
国药准字S10960013
Approval Date
Nov 18, 2020
NMPA

BCG Polysaccharide and Nucleic Acid Injection

Product Name
卡舒宁
Approval Number
国药准字S19983036
Approval Date
Nov 18, 2020
NMPA

Vi Polysaccharide Typhoid Vaccine

Product Name
伤寒Vi多糖疫苗
Approval Number
国药准字S10960097
Approval Date
Nov 18, 2020
NMPA

Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine,Adsorbed

Product Name
山联泰
Approval Number
国药准字S10970013
Approval Date
May 11, 2020
NMPA

BCG Vaccine for Intradermal Injection

Product Name
皮内注射用卡介苗
Approval Number
国药准字S20013057
Approval Date
May 11, 2020
NMPA

Purified Protein Derivative of BCG

Product Name
卡介菌纯蛋白衍生物(BCG-PPD)
Approval Number
国药准字S20010052
Approval Date
Apr 27, 2020
NMPA

Japanese Encephalitis Vaccine,Live

Product Name
杰益维
Approval Number
国药准字S10900004
Approval Date
Feb 25, 2020
NMPA

Recombinant Human Granulocyte Colony-stimulating Factor Injection

Product Name
保力津
Approval Number
国药准字S20053010
Approval Date
Feb 25, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.